Pages that link to "Q36252318"
Jump to navigation
Jump to search
The following pages link to Identification of SPLUNC1's ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airways (Q36252318):
Displaying 7 items.
- Dual acute proinflammatory and antifibrotic pulmonary effects of short palate, lung, and nasal epithelium clone-1 after exposure to carbon nanotubes (Q23923985) (← links)
- Structural characterization of the pulmonary innate immune protein SPLUNC1 and identification of lipid ligands (Q34512927) (← links)
- Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria (Q34760695) (← links)
- Structural Features Essential to the Antimicrobial Functions of Human SPLUNC1. (Q36952231) (← links)
- Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis (Q36999197) (← links)
- Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis (Q41553158) (← links)
- Inhaled Biologicals for the Treatment of Cystic Fibrosis (Q57476855) (← links)